MAP
Madison Avenue Partners Portfolio holdings
AUM
$1.5B
This Quarter Return
+22.93%
1 Year Return
+26.66%
3 Year Return
+137.23%
5 Year Return
+278.64%
10 Year Return
–
AUM
$705M
AUM Growth
+$705M
(+54%)
Cap. Flow
+$252M
Cap. Flow
% of AUM
35.69%
Top 10 Holdings %
Top 10 Hldgs %
95.7%
Holding
24
New
5
Increased
5
Reduced
4
Closed
4
Top Buys
| 1 |
SharkNinja
SN
|
$283M |
| 2 |
TSVT
2seventy bio
TSVT
|
$5.86M |
| 3 |
Graham Holdings Company
GHC
|
$5.2M |
| 4 |
Gossamer Bio
GOSS
|
$5.11M |
| 5 |
Cartesian Therapeutics
RNAC
|
$4.25M |
Top Sells
| 1 |
First Horizon
FHN
|
$20.8M |
| 2 |
G-III Apparel Group
GIII
|
$18.1M |
| 3 |
MasterBrand
MBC
|
$15.1M |
| 4 |
ONL
Orion Office REIT
ONL
|
$3.1M |
| 5 |
Sylvamo
SLVM
|
$1.62M |
Sector Composition
| 1 | Consumer Discretionary | 51.49% |
| 2 | Healthcare | 19.16% |
| 3 | Consumer Staples | 17.32% |
| 4 | Communication Services | 4.76% |
| 5 | Real Estate | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SharkNinja
SN
$16.5B
| $283M | 40.21% | +6,112,191 | New | +$283M |
|
|
2
Graham Holdings Company
GHC
$4.74B
| $122M | 17.32% | 209,401 +8,917 | +4% | +$5.2M |
|
|
3
G-III Apparel Group
GIII
$1.17B
| $79.5M | 11.28% | 3,188,997 -725,872 | -19% | -$18.1M |
|
4
Theravance Biopharma
TBPH
$699M
| $60.5M | 8.59% | 7,012,226 | – | – |
|
5
Integra LifeSciences
IART
$1.18B
| $36.8M | 5.23% | 964,667 +40,000 | +4% | +$1.53M |
|
6
Stagwell
STGW
$1.46B
| $33.5M | 4.76% | 7,147,662 | – | – |
|
|
PFSW
7
DELISTED
PFSweb, Inc.
PFSW
| $19.6M | 2.78% | 2,633,189 | – | – |
|
|
ONL
8
Orion Office REIT
ONL
$167M
| $18.2M | 2.59% | 3,501,281 -594,620 | -15% | -$3.1M |
|
9
Ovid Therapeutics
OVID
$91M
| $14M | 1.99% | 3,648,509 +340,904 | +10% | +$1.31M |
|
|
MACK
10
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $6.82M | 0.97% | 553,085 | – | – |
|
|
FSP
11
Franklin Street Properties
FSP
$172M
| $6.09M | 0.86% | 3,291,443 +1,288,790 | +64% | +$2.38M |
|
|
TSVT
12
DELISTED
2seventy bio
TSVT
| $5.86M | 0.83% | +1,494,125 | New | +$5.86M |
|
|
13
Gossamer Bio
GOSS
$562M
| $5.11M | 0.72% | +6,130,268 | New | +$5.11M |
|
|
14
Cartesian Therapeutics
RNAC
$261M
| $4.25M | 0.6% | +4,008,019 | New | +$4.25M |
|
15
MBIA
MBI
$402M
| $3.03M | 0.43% | 420,826 | – | – |
|
16
Vestis
VSTS
$617M
| $2.12M | 0.3% | +110,000 | New | +$2.12M |
|
|
CEE
17
Central and Eastern Europe Fund
CEE
$105M
| $1.81M | 0.26% | 211,030 | – | – |
|
18
Indivior
INDV
$3.03B
| $902K | 0.13% | 39,087 +27,887 | +249% | +$643K |
|
19
LENSAR
LNSR
$147M
| $743K | 0.11% | 240,341 -117,122 | -33% | -$362K |
|
|
SFE
20
DELISTED
Safeguard Scientifics, Inc.
SFE
| $359K | 0.05% | 359,085 -32,374 | -8% | -$32.4K |
|
|
21
First Horizon
FHN
$11.5B
| – | – | -1,843,065 | Closed | -$20.8M |
|
22
James River Group
JRVR
$258M
| – | – | -63,887 | Closed | -$1.17M |
|
|
23
MasterBrand
MBC
$1.61B
| – | – | -1,298,688 | Closed | -$15.1M |
|
|
24
Sylvamo
SLVM
$1.86B
| – | – | -40,163 | Closed | -$1.62M |
|